KR Choksey has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Glenmark Pharma September quarter net sales are expected to go up by 11% at
Rs 819 crore, year-on-year, (YoY) basis.
The company's net profit is expected to go down 8% at Rs 102 cr crore on YoY basis.
....more info
Rs 819 crore, year-on-year, (YoY) basis.
The company's net profit is expected to go down 8% at Rs 102 cr crore on YoY basis.
....more info